Work

Doubling down on PK activation for sickle cell disease

Year: 2024

Type: article

Source: Blood Advances

DOI: 10.1182/bloodadvances.2024013367

Authors: Samuel R. Wilson, Lydia H. Pecker

Institutions: University of North Carolina at Chapel Hill, Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: Andrew W. Mellon Foundation, Alexion Pharmaceuticals, Agios Pharmaceuticals, Novo Nordisk, National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA, Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease

OpenAlex ID: W4401909515

FWCI:

Cites: 8

Cited by:

Related to: 10